The α7β0 isoform of the complement regulator C4b-binding protein induces a semimature, anti-inflammatory state in dendritic cells

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2857-2872

  Olivar, Rut ^a   Luque, Ana ^a   Mar, Naranjo Gómez ^b   Quer, Josep ^b   De Frutos, Pablo García ^c   Borràs, Francesc E ^a,b   De Córdoba, Santiago Rodríguez ^a,d   Blom, Anna M ^a,e   Aran, Josep M ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INST D INVESTIGACIONS B   (Spain)

^d CSIC   (Spain)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD12 ANTIGEN; CD4 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; COMPLEMENT COMPONENT C4B BINDING PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; ISOPROTEIN; LIPOPOLYSACCHARIDE; POLYPEPTIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANTIGEN EXPRESSION; ARTICLE; BETA CHAIN; BIC 1 GENE; CELL ACTIVATION; CELL ACTIVITY; CELL MATURATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; GENE; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IDO GENE; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TGF BETA1 GENE; UPREGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIFFERENTIATION; COMPLEMENT C4B-BINDING PROTEIN; DENDRITIC CELLS; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; PROTEIN ISOFORMS;

EID: 84874842539     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200503     Document Type: Article

References (58)

1. Carroll, M. C. 2004. The complement system in regulation of adaptive immunity. Nat. Immunol. 5: 981-986.
2. Zipfel, P. F., and C. Skerka. 2009. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9: 729-740.
3. Sjöberg, A. P., L. A. Trouw, and A. M. Blom. 2009. Complement activation and inhibition: a delicate balance. Trends Immunol. 30: 83-90.
4. Sánchez-Corral, P., O. Criado García, and S. Rodríguez de Córdoba. 1995. Isoforms of human C4b-binding protein. I. Molecular basis for the C4BP isoform pattern and its variations in human plasma. J. Immunol. 155: 4030-4036.
5. Hillarp, A., and B. Dahlbäck. 1990. Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain. Proc. Natl. Acad. Sci. USA 87: 1183-1187.
6. Dahlbäck, B. 1983. Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem. J. 209: 847- 856.
7. Kask, L., A. Hillarp, B. Ramesh, B. Dahlbäck, and A. M. Blom. 2002. Structural requirements for the intracellular subunit polymerization of the complement inhibitor C4b-binding protein. Biochemistry 41: 9349-9357.
8. Chung, L. P., D. R. Bentley, and K. B. Reid. 1985. Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system. Biochem. J. 230: 133-141.
9. Gigli, I., T. Fujita, and V. Nussenzweig. 1979. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. USA 76: 6596-6600.
10. Scharfstein, J., A. Ferreira, I. Gigli, and V. Nussenzweig. 1978. Human C4- binding protein. I. Isolation and characterization. J. Exp. Med. 148: 207-222.
11. Trouw, L. A., S. C. Nilsson, I. Gonçalves, G. Landberg, and A. M. Blom. 2005. C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation. J. Exp. Med. 201: 1937-1948.
12. Trouw, L. A., A. A. Bengtsson, K. A. Gelderman, B. Dahlbäck, G. Sturfelt, and A. M. Blom. 2007. C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. J. Biol. Chem. 282: 28540-28548.
13. García de Frutos, P., R. I. Alim, Y. Härdig, B. Zöller, and B. Dahlbäck. 1994. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 84: 815-822.
14. Criado García, O., P. Sánchez-Corral, and S. Rodríguez de Córdoba. 1995. Isoforms of human C4b-binding protein. II. Differential modulation of the C4BPA and C4BPB genes by acute phase cytokines. J. Immunol. 155: 4037- 4043.
15. Blom, A. M., K. S. Nandakumar, and R. Holmdahl. 2009. C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice. Ann. Rheum. Dis. 68: 136-142.
16. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
17. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
18. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
19. Manicassamy, S., and B. Pulendran. 2011. Dendritic cell control of tolerogenic responses. Immunol. Rev. 241: 206-227.
20. Mahnke, K., E. Schmitt, L. Bonifaz, A. H. Enk, and H. Jonuleit. 2002. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80: 477-483.
21. Blom, A. M., B. O. Villoutreix, and B. Dahlbäck. 2004. Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Mol. Immunol. 40: 1333-1346.
22. Brodeur, S. R., F. Angelini, L. B. Bacharier, A. M. Blom, E. Mizoguchi, H. Fujiwara, A. Plebani, L. D. Notarangelo, B. Dahlback, E. Tsitsikov, and R. S. Geha. 2003. C4b-binding protein (C4BP) activates B cells through the CD40 receptor. Immunity 18: 837-848.
23. Blom, A. M., L. Kask, and B. Dahlbäck. 2001. Structural requirements for the complement regulatory activities of C4BP. J. Biol. Chem. 276: 27136-27144.
24. Jin, P., T. H. Han, J. Ren, S. Saunders, E. Wang, F. M. Marincola, and D. F. Stroncek. 2010. Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies. J. Transl. Med. 8: 4.
25. Blom, A. M., T. Hallström, and K. Riesbeck. 2009. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol. Immunol. 46: 2808-2817.
26. Segerer, S. E., N. Müller, Jv. Brandt, M. Kapp, J. Dietl, H. M. Reichardt, L. Rieger, and U. Kämmerer. 2008. The glycoprotein-hormones activin A and inhibin A interfere with dendritic cell maturation. Reprod. Biol. Endocrinol. 6: 17.
27. Wang, J., G. Roderiquez, T. Jones, P. McPhie, and M. A. Norcross. 2007. Control of in vitro immune responses by regulatory oligodeoxynucleotides through inhibition of pIII promoter directed expression of MHC class II transactivator in human primary monocytes. J. Immunol. 179: 45-52.
28. Steinbrink, K., M. Wölfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159: 4772-4780.
29. Gabrilovich, D. I., H. L. Chen, K. R. Girgis, H. T. Cunningham, G. M. Meny, S. Nadaf, D. Kavanaugh, and D. P. Carbone. 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2: 1096-1103.
30. Gonzalez-Rey, E., A. Chorny, A. Fernandez-Martin, D. Ganea, and M. Delgado. 2006. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 107: 3632-3638.
31. Canning, M. O., K. Grotenhuis, H. de Wit, C. Ruwhof, and H. A. Drexhage. 2001. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 145: 351-357.
32. Nauta, A. J., A. B. Kruisselbrink, E. Lurvink, R. Willemze, andW. E. Fibbe. 2006. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 177: 2080-2087.
33. Piemonti, L., P. Monti, P. Allavena, M. Sironi, L. Soldini, B. E. Leone, C. Socci, and V. Di Carlo. 1999. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162: 6473-6481.
34. Szabo, G., C. Gavala, and P. Mandrekar. 2001. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. J. Investig. Med. 49: 442-449.
35. Riol-Blanco, L., N. Sánchez-Sánchez, A. Torres, A. Tejedor, S. Narumiya, A. L. Corbí, P. Sánchez-Mateos, and J. L. Rodríguez-Fernández. 2005. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J. Immunol. 174: 4070- 4080.
36. Ceppi, M., P. M. Pereira, I. Dunand-Sauthier, E. Barras, W. Reith, M. A. Santos, and P. Pierre. 2009. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. USA 106: 2735-2740.
37. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.
38. Von Bubnoff, D., M. Scheler, H. Wilms, R. Fimmers, and T. Bieber. 2011. Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli. J. Immunol. 186: 6701-6709.
39. Li, M. O., Y. Y. Wan, S. Sanjabi, A. K. Robertson, and R. A. Flavell. 2006. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24: 99-146.
40. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182: 389-400.
41. Hackstein, H., T. Taner, A. J. Logar, and A. W. Thomson. 2002. Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. Blood 100: 1084-1087.
42. Berer, A., J. Stöckl, O. Majdic, T. Wagner, M. Kollars, K. Lechner, K. Geissler, and L. Oehler. 2000. 1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp. Hematol. 28: 575-583.
43. Saraiva, M., and A. O'Garra. 2010. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 10: 170-181.
44. Sánchez-Sánchez, N., L. Riol-Blanco, and J. L. Rodríguez-Fernández. 2006. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol. 176: 5153-5159.
45. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell 106: 263-266.
46. Roncarolo, M. G., M. K. Levings, and C. Traversari. 2001. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193: F5-F9.
47. Smits, H. H., E. C. de Jong, E. A. Wierenga, and M. L. Kapsenberg. 2005. Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 26: 123-129.
48. Coombes, J. L., K. R. Siddiqui, C. V. Arancibia-Cárcamo, J. Hall, C. M. Sun, Y. Belkaid, and F. Powrie. 2007. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
49. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731.
50. Csomor, E., Z. Bajtay, N. Sándor, K. Kristóf, G. J. Arlaud, S. Thiel, and A. Erdei. 2007. Complement protein C1q induces maturation of human dendritic cells. Mol. Immunol. 44: 3389-3397.
51. Teh, B. K., J. G. Yeo, L. M. Chern, and J. Lu. 2011. C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Mol. Immunol. 48: 1128-1138.
52. Reis, E. S., J. A. Barbuto, J. Kö hl, and L. Isaac. 2008. Impaired dendritic cell differentiation and maturation in the absence of C3. Mol. Immunol. 45: 1952- 1962.
53. Takahara, M., K. Kang, L. Liu, Y. Yoshida, T. S. McCormick, and K. D. Cooper. 2003. iC3b arrests monocytic cell differentiation into CD1c-expressing dendritic cell precursors: a mechanism for transiently decreased dendritic cells in vivo after human skin injury by ultraviolet B. J. Invest. Dermatol. 120: 802-809.
54. Blom, A. M., B. O. Villoutreix, and B. Dahlbäck. 2004. Functions of human complement inhibitor C4b-binding protein in relation to its structure. Arch. Immunol. Ther. Exp. (Warsz.) 52: 83-95.
55. Dahlbäck, B. 1991. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb. Haemost. 66: 49- 61.
56. García de Frutos, P., Y. Härdig, and B. Dahlbäck. 1995. Serum amyloid P component binding to C4b-binding protein. J. Biol. Chem. 270: 26950-26955.
57. Williams, K. T., S. P. Young, A. Negus, L. S. Young, D. H. Adams, and S. C. Afford. 2007. C4b binding protein binds to CD154 preventing CD40 mediated cholangiocyte apoptosis: a novel link between complement and epithelial cell survival. PLoS ONE 2: e159.
58. Lavery, L. W., and M. H. Goyns. 2002. Decline in the expression of C4 binding protein alpha-chain gene during ageing of the rat liver. Biogerontology 3: 207- 211.